» Authors » Machiko Kusuda

Machiko Kusuda

Explore the profile of Machiko Kusuda including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 58
Citations 132
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ishikawa T, Kawamura M, Takeshita J, Ito S, Wada H, Matsuda Y, et al.
Rinsho Ketsueki . 2025 Feb; 65(11):1388-1392. PMID: 39935226
We report the case of a 65-year-old man who was diagnosed with Bickerstaff brainstem encephalitis prior to central nervous system (CNS) relapse of diffuse large B-cell lymphoma (DLBCL). He was...
2.
Nakata Y, Yoshino N, Kusuda M, Kimura S, Matsuoka A, Meno T, et al.
J Infect Chemother . 2025 Feb; 31(4):102649. PMID: 39922460
Talaromyces columbinus was previously reported in two patients with lung infections under the name Penicillium piceum and one case of dual infection with Aspergillus calidoustus was recently reported.; currently, no...
3.
Gomyo A, Kako S, Kawamura M, Kawamura S, Takeshita J, Yoshino N, et al.
Int J Hematol . 2025 Feb; PMID: 39912986
Rapid tapering of cyclosporine (CsA) in the early phase after allogeneic transplantation may induce a potent graft-versus-leukemia/lymphoma (GVL) effect. We retrospectively reviewed the outcomes of patients with high-risk hematological malignancies...
4.
Kawamura S, Fujiwara S, Kimura S, Takeshita J, Nakasone H, Yoshimura K, et al.
Transplant Cell Ther . 2025 Jan; 31(3):184.e1-184.e11. PMID: 39828058
We previously reported that the area under the curve of log-transformed cytomegalovirus antigenemia (CMV-AUC) until 100 days after allogeneic hematopoietic cell transplantation (allo-HCT) was associated with an increased risk of...
5.
Yoshino N, Kimura S, Kawamura K, Nakata Y, Matsuoka A, Ishikawa T, et al.
J Infect Chemother . 2024 Jun; 31(1):102455. PMID: 38925426
Background: A change in empirical antibiotics or the addition of glycopeptide antibiotics is often applied in cases of persistent febrile neutropenia (FN) despite the administration of broad-spectrum antibiotics. However, the...
6.
Okada Y, Nakasone H, Kawamura S, Takano K, Yoshimura K, Tamaki M, et al.
Haematologica . 2024 Jun; 109(11):3593-3601. PMID: 38899343
The recent progress with ruxolitinib treatment might improve quality of life as well as overall survival in patients with primary myelofibrosis. Therefore, the optimal timing of allogeneic hematopoietic cell transplantation...
7.
Gomyo A, Kimura S, Suzuki J, Ishikawa T, Meno T, Matsuoka A, et al.
Transplant Cell Ther . 2023 Aug; 29(11):721.e1-721.e8. PMID: 37643718
Clinical research regarding the impact of pretransplantation physical function on transplantation outcomes in older adults remains limited. We retrospectively reviewed the charts of 150 consecutive patients age >55 years who...
8.
Matsumi S, Kimura S, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, et al.
Int J Hematol . 2023 Jul; 118(4):450-461. PMID: 37480446
Combination of calcineurin inhibitors (CIs) with short-term methotrexate is a standard prophylactic regimen for graft-versus-host disease (GVHD). However, it is sometimes difficult to continue CIs due to adverse effects, such...
9.
Okada Y, Nakasone H, Yoshimura K, Tamaki M, Kusuda M, Nakamura Y, et al.
Int J Hematol . 2023 Jul; 118(3):340-346. PMID: 37480445
Several biofluid-based biomarkers for traumatic brain injury show promise for use in diagnosis and outcome prediction. In contrast, few studies have investigated biomarkers for non-traumatic brain injury. We focused on...
10.
Kusuda M, Nakasone H, Yoshimura K, Okada Y, Tamaki M, Matsuoka A, et al.
Br J Haematol . 2023 Jun; 202(3):578-588. PMID: 37317804
Adult T-cell leukaemia/lymphoma (ATL) is an aggressive malignancy of peripheral T cells caused by human T-cell lymphotropic virus type-1 (HTLV-1). Tax is the most important regulatory protein for HTLV-1. We...